Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19


Development of a multiplexed urine assay for prostate cancer diagnosis.

Vener T, Derecho C, Baden J, Wang H, Rajpurohit Y, Skelton J, Mehrotra J, Varde S, Chowdary D, Stallings W, Leibovich B, Robin H, Pelzer A, Schäfer G, Auprich M, Mannweiler S, Amersdorfer P, Mazumder A.

Clin Chem. 2008 May;54(5):874-82. doi: 10.1373/clinchem.2007.094912. Epub 2008 Mar 13.


Quantitative, spatial resolution of the epigenetic field effect in prostate cancer.

Mehrotra J, Varde S, Wang H, Chiu H, Vargo J, Gray K, Nagle RB, Neri JR, Mazumder A.

Prostate. 2008 Feb 1;68(2):152-60.


Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform.

Maris JM, Hii G, Gelfand CA, Varde S, White PS, Rappaport E, Surrey S, Fortina P.

Genome Res. 2005 Aug;15(8):1168-76.


High-density single-nucleotide polymorphism maps of the human genome.

Miller RD, Phillips MS, Jo I, Donaldson MA, Studebaker JF, Addleman N, Alfisi SV, Ankener WM, Bhatti HA, Callahan CE, Carey BJ, Conley CL, Cyr JM, Derohannessian V, Donaldson RA, Elosua C, Ford SE, Forman AM, Gelfand CA, Grecco NM, Gutendorf SM, Hock CR, Hozza MJ, Hur S, In SM, Jackson DL, Jo SA, Jung SC, Kim S, Kimm K, Kloss EF, Koboldt DC, Kuebler JM, Kuo FS, Lathrop JA, Lee JK, Leis KL, Livingston SA, Lovins EG, Lundy ML, Maggan S, Minton M, Mockler MA, Morris DW, Nachtman EP, Oh B, Park C, Park CW, Pavelka N, Perkins AB, Restine SL, Sachidanandam R, Reinhart AJ, Scott KE, Shah GJ, Tate JM, Varde SA, Walters A, White JR, Yoo YK, Lee JE, Boyce-Jacino MT, Kwok PY; SNP Consortium Allele Frequency Project.

Genomics. 2005 Aug;86(2):117-26.


Auto-validation of fluorescent primer extension genotyping assay using signal clustering and neural networks.

Huang CY, Studebaker J, Yuryev A, Huang J, Scott KE, Kuebler J, Varde S, Alfisi S, Gelfand CA, Pohl M, Boyce-Jacino MT.

BMC Bioinformatics. 2004 Apr 2;5:36.


Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots.

Phillips MS, Lawrence R, Sachidanandam R, Morris AP, Balding DJ, Donaldson MA, Studebaker JF, Ankener WM, Alfisi SV, Kuo FS, Camisa AL, Pazorov V, Scott KE, Carey BJ, Faith J, Katari G, Bhatti HA, Cyr JM, Derohannessian V, Elosua C, Forman AM, Grecco NM, Hock CR, Kuebler JM, Lathrop JA, Mockler MA, Nachtman EP, Restine SL, Varde SA, Hozza MJ, Gelfand CA, Broxholme J, Abecasis GR, Boyce-Jacino MT, Cardon LR.

Nat Genet. 2003 Mar;33(3):382-7. Epub 2003 Feb 18.


SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery.

Bell PA, Chaturvedi S, Gelfand CA, Huang CY, Kochersperger M, Kopla R, Modica F, Pohl M, Varde S, Zhao R, Zhao X, Boyce-Jacino MT, Yassen A.

Biotechniques. 2002 Jun;Suppl:70-2, 74, 76-7. Erratum in: Biotechniques. 2003 Mar;34(3):496.


Lyme disease: disparity between culture and polymerase chain reaction detection of Borrelia burgdorferi after exposure to ceftriaxone in vitro.

Varde S, Wormser GP, Nowakowski J, Nadelman RB, Bittker S, Cooper D, Schwartz I.

Conn Med. 1999 Oct;63(10):589-91.


Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens.

Liveris D, Varde S, Iyer R, Koenig S, Bittker S, Cooper D, McKenna D, Nowakowski J, Nadelman RB, Wormser GP, Schwartz I.

J Clin Microbiol. 1999 Mar;37(3):565-9.


Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia.

Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, Maraspin V, Aguero-Rosenfeld ME, Varde S, Lotric-Furlan S, Wormser GP.

Ann Intern Med. 1999 Jan 5;130(1):32-6.


Geographic risk for lyme disease and human granulocytic ehrlichiosis in southern New York state.

Daniels TJ, Boccia TM, Varde S, Marcus J, Le J, Bucher DJ, Falco RC, Schwartz I.

Appl Environ Microbiol. 1998 Dec;64(12):4663-9.


Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases.

Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, Holmgren D, Hsieh TC, Varde SA, Dumler SJ, Wu JM, Schwartz I, Rikihisa Y, Wormser GP.

Clin Infect Dis. 1998 Nov;27(5):1314-7.


Prevalence of tick-borne pathogens in Ixodes scapularis in a rural New Jersey County.

Varde S, Beckley J, Schwartz I.

Emerg Infect Dis. 1998 Jan-Mar;4(1):97-9.


Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis.

Nadelman RB, Horowitz HW, Hsieh TC, Wu JM, Aguero-Rosenfeld ME, Schwartz I, Nowakowski J, Varde S, Wormser GP.

N Engl J Med. 1997 Jul 3;337(1):27-30. No abstract available.


Deer ticks (Ixodes scapularis) and the agents of Lyme disease and human granulocytic ehrlichiosis in a New York City park.

Daniels TJ, Falco RC, Schwartz I, Varde S, Robbins RG.

Emerg Infect Dis. 1997 Jul-Sep;3(3):353-5.


Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE).

Hsieh TC, Aguero-Rosenfeld ME, Wu JM, Ng C, Papanikolaou NA, Varde SA, Schwartz I, Pizzolo JG, Melamed M, Horowitz HW, Nadelman RB, Wormser GP.

Biochem Biophys Res Commun. 1997 Mar 17;232(2):298-303.


Inhibition of efficient polymerase chain reaction amplification of Borrelia burgdorferi DNA in blood-fed ticks.

Schwartz I, Varde S, Nadelman RB, Wormser GP, Fish D.

Am J Trop Med Hyg. 1997 Mar;56(3):339-42.


Positive Lyme disease serology in patients with clinical and laboratory evidence of human granulocytic ehrlichiosis.

Wormser GP, Horowitz HW, Nowakowski J, McKenna D, Dumler JS, Varde S, Schwartz I, Carbonaro C, Aguero-Rosenfeld M.

Am J Clin Pathol. 1997 Feb;107(2):142-7.


Molecular typing of Borrelia burgdorferi from Lyme disease patients by PCR-restriction fragment length polymorphism analysis.

Liveris D, Wormser GP, Nowakowski J, Nadelman R, Bittker S, Cooper D, Varde S, Moy FH, Forseter G, Pavia CS, Schwartz I.

J Clin Microbiol. 1996 May;34(5):1306-9.

Supplemental Content

Support Center